|
|
 |
|
Viewing report
|
|
|
|
AstraZeneca PLC: Company Profile and SWOT Analysis
iCD Research, Sep 2011, Pages: 75
Synopsis
ICD Research's 'AstraZeneca PLC: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's 'AstraZeneca PLC: Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about AstraZeneca PLC for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios of the company
- The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors’ businesses better
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures
Key Highlights
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company, engaged in the discovery, development, production and marketing of a broad range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Its research and development activities are focused on the development of implants and medical devices with principle focus on type 2 diabetes, infection, COPD, cancer, Alzheimer's diseases and other areas. The company has presence in more than 100 countries throughout the world. It has 17 research and development sites in eight countries as well as 20 manufacturing plants in 16 countries. AstraZeneca is headquartered in London, the UK.
|
|
|
|
